Clinical Trial Update: NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for TONIC-3 evaluating novel immunotherapy strategies in advanced/metastatic triple-negative breast cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING